109 related articles for article (PubMed ID: 2109590)
1. A CD 4: immunoglobulin fusion protein with antiviral effects against HIV.
Gregersen JP; Mehdi S; Gelderblom H; Zettlmeissl G
Arch Virol; 1990; 111(1-2):29-43. PubMed ID: 2109590
[TBL] [Abstract][Full Text] [Related]
2. Antiviral effects of different CD4-immunoglobulin constructs against HIV-1 and SIV: immunological characterization, pharmacokinetic data and in vivo experiments.
Langner KD; Niedrig M; Fultz P; Anderson D; Reiner G; Repke H; Gelderblom H; Seed B; Hilfenhaus J; Zettlmeissl G
Arch Virol; 1993; 130(1-2):157-70. PubMed ID: 8503781
[TBL] [Abstract][Full Text] [Related]
3. Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules.
Traunecker A; Schneider J; Kiefer H; Karjalainen K
Nature; 1989 May; 339(6219):68-70. PubMed ID: 2541344
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a mouse/human chimeric monoclonal antibody (C beta 1) to a principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
Matsushita S; Maeda H; Kimachi K; Eda Y; Maeda Y; Murakami T; Tokiyoshi S; Takatsuki K
AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1107-15. PubMed ID: 1380258
[TBL] [Abstract][Full Text] [Related]
5. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
[TBL] [Abstract][Full Text] [Related]
6. Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1.
Chen W; Bardhi A; Feng Y; Wang Y; Qi Q; Li W; Zhu Z; Dyba MA; Ying T; Jiang S; Goldstein H; Dimitrov DS
MAbs; 2016; 8(4):761-74. PubMed ID: 26963639
[TBL] [Abstract][Full Text] [Related]
7. Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation.
Howard OM; Clouse KA; Smith C; Goodwin RG; Farrar WL
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2335-9. PubMed ID: 7681592
[TBL] [Abstract][Full Text] [Related]
8. Expression and characterization of human CD4:immunoglobulin fusion proteins.
Zettlmeissl G; Gregersen JP; Duport JM; Mehdi S; Reiner G; Seed B
DNA Cell Biol; 1990 Jun; 9(5):347-53. PubMed ID: 2196903
[TBL] [Abstract][Full Text] [Related]
9. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
[TBL] [Abstract][Full Text] [Related]
10. Engineering and functional evaluation of a single-chain antibody against HIV-1 external glycoprotein gp120.
Wang HW; Cole D; Jiang WZ; Jin HT; Fu N; Chen ZL; Jin NY
Clin Exp Immunol; 2005 Jul; 141(1):72-80. PubMed ID: 15958072
[TBL] [Abstract][Full Text] [Related]
11. Expression and characterization of CD4-IgG2, a novel heterotetramer that neutralizes primary HIV type 1 isolates.
Allaway GP; Davis-Bruno KL; Beaudry GA; Garcia EB; Wong EL; Ryder AM; Hasel KW; Gauduin MC; Koup RA; McDougal JS
AIDS Res Hum Retroviruses; 1995 May; 11(5):533-9. PubMed ID: 7576908
[TBL] [Abstract][Full Text] [Related]
12. Complement-mediated enhancement of HIV-1 neutralisation by anti-HLA antibodies derived from polytransfused patients.
Wilfingseder D; Spruth M; Ammann CG; Döpper S; Speth C; Dierich MP; Stoiber H
Int Arch Allergy Immunol; 2003 May; 131(1):62-72. PubMed ID: 12759492
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor.
Dey B; Del Castillo CS; Berger EA
J Virol; 2003 Mar; 77(5):2859-65. PubMed ID: 12584309
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 neutralization by chimeric CD4-CG10 polypeptides fused to human IgG1.
Meyuhas R; Noy H; Montefiori DC; Denisova G; Gershoni JM; Gross G
Mol Immunol; 2005 May; 42(9):1099-109. PubMed ID: 15829299
[TBL] [Abstract][Full Text] [Related]
16. Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1.
Hezareh M; Hessell AJ; Jensen RC; van de Winkel JG; Parren PW
J Virol; 2001 Dec; 75(24):12161-8. PubMed ID: 11711607
[TBL] [Abstract][Full Text] [Related]
17. Synergistic inhibition of HIV-1 envelope-mediated cell fusion by CD4-based molecules in combination with antibodies to gp120 or gp41.
Allaway GP; Ryder AM; Beaudry GA; Maddon PJ
AIDS Res Hum Retroviruses; 1993 Jul; 9(7):581-7. PubMed ID: 8369162
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates.
Kessler JA; McKenna PM; Emini EA; Chan CP; Patel MD; Gupta SK; Mark GE; Barbas CF; Burton DR; Conley AJ
AIDS Res Hum Retroviruses; 1997 May; 13(7):575-82. PubMed ID: 9135875
[TBL] [Abstract][Full Text] [Related]
19. eCD4-Ig Variants That More Potently Neutralize HIV-1.
Fetzer I; Gardner MR; Davis-Gardner ME; Prasad NR; Alfant B; Weber JA; Farzan M
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593050
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cell surface molecules during HIV-1 infection of H9 cells. An immunoelectron microscopic study.
Meerloo T; Parmentier HK; Osterhaus AD; Goudsmit J; Schuurman HJ
AIDS; 1992 Oct; 6(10):1105-16. PubMed ID: 1466841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
